DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease
MANUFACTURER: AstraZeneca Pharmaceuticals LP
USAGE: Oral
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Breztri Aerosphere is a prescription medication that combines three active ingredients: budesonide, glycopyrrolate, and formoterol fumarate. This combination inhaler is primarily used in the management of chronic obstructive pulmonary disease (COPD), a chronic lung condition characterized by airflow limitation and breathing difficulties.